Literature DB >> 16441239

Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity.

Patrick A Lewis1, Francesca Properzi, Kanella Prodromidou, Anthony R Clarke, John Collinge, Graham S Jackson.   

Abstract

According to the protein-only hypothesis of prion propagation, prions are composed principally of PrP(Sc), an abnormal conformational isoform of the prion protein, which, like its normal cellular precursor (PrP(C)), has a GPI (glycosylphosphatidylinositol) anchor at the C-terminus. To date, elucidating the role of this anchor on the infectivity of prion preparations has not been possible because of the resistance of PrP(Sc) to the activity of PI-PLC (phosphoinositide-specific phospholipase C), an enzyme which removes the GPI moiety from PrP(C). Removal of the GPI anchor from PrP(Sc) requires denaturation before treatment with PI-PLC, a process that also abolishes infectivity. To circumvent this problem, we have removed the GPI anchor from PrP(Sc) in RML (Rocky Mountain Laboratory)-prion-infected murine brain homogenate using the aspartic endoprotease cathepsin D. This enzyme eliminates a short sequence at the C-terminal end of PrP to which the GPI anchor is attached. We found that this modification has no effect (i) on an in vitro amplification model of PrP(Sc), (ii) on the prion titre as determined by a highly sensitive N2a-cell based bioassay, or (iii) in a mouse bioassay. These results show that the GPI anchor has little or no role in either the propagation of PrP(Sc) or on prion infectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16441239      PMCID: PMC1422754          DOI: 10.1042/BJ20051677

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration.

Authors:  A Kenessey; P Nacharaju; L W Ko; S H Yen
Journal:  J Neurochem       Date:  1997-11       Impact factor: 5.372

2.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

3.  In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups.

Authors:  Ralf Lucassen; Koren Nishina; Surachai Supattapone
Journal:  Biochemistry       Date:  2003-04-15       Impact factor: 3.162

4.  Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors.

Authors:  R Narwa; D A Harris
Journal:  Biochemistry       Date:  1999-07-06       Impact factor: 3.162

Review 5.  The structure and biosynthesis of glycosyl phosphatidylinositol protein anchors.

Authors:  P T Englund
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

6.  The genetic association between Cathepsin D and Alzheimer's disease.

Authors:  F C Crawford; M J Freeman; J Schinka; L I Abdullah; D Richards; S Sevush; R Duara; M J Mullan
Journal:  Neurosci Lett       Date:  2000-07-28       Impact factor: 3.046

7.  Human prion protein cDNA: molecular cloning, chromosomal mapping, and biological implications.

Authors:  Y C Liao; R V Lebo; G A Clawson; E A Smuckler
Journal:  Science       Date:  1986-07-18       Impact factor: 47.728

Review 8.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

9.  Mice devoid of PrP are resistant to scrapie.

Authors:  H Büeler; A Aguzzi; A Sailer; R A Greiner; P Autenried; M Aguet; C Weissmann
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

Review 10.  Prions and prion proteins.

Authors:  N Stahl; S B Prusiner
Journal:  FASEB J       Date:  1991-10       Impact factor: 5.191

View more
  9 in total

1.  Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation.

Authors:  Leonid Breydo; Ying Sun; Natallia Makarava; Cheng-I Lee; Vera Novitskaia; Olga Bocharova; Joseph P Y Kao; Ilia V Baskakov
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

2.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

Review 3.  Prions: Beyond a Single Protein.

Authors:  Alvin S Das; Wen-Quan Zou
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

Review 4.  Implications of peptide assemblies in amyloid diseases.

Authors:  Pu Chun Ke; Marc-Antonie Sani; Feng Ding; Aleksandr Kakinen; Ibrahim Javed; Frances Separovic; Thomas P Davis; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2017-10-30       Impact factor: 54.564

5.  Cardiac glycoside-mediated turnover of Na, K-ATPases as a rational approach to reducing cell surface levels of the cellular prion protein.

Authors:  Mohadeseh Mehrabian; Xinzhu Wang; Shehab Eid; Bei Qi Yan; Mark Grinberg; Murdock Siegner; Christopher Sackmann; Muhammad Sulman; Wenda Zhao; Declan Williams; Gerold Schmitt-Ulms
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

Review 6.  Prion stability and infectivity in the environment.

Authors:  Richard C Wiggins
Journal:  Neurochem Res       Date:  2008-05-16       Impact factor: 3.996

Review 7.  Cell biology of prion strains in vivo and in vitro.

Authors:  Daniel Shoup; Suzette A Priola
Journal:  Cell Tissue Res       Date:  2022-02-02       Impact factor: 5.249

8.  Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts.

Authors:  Fiorella Malchiodi-Albedi; Silvia Paradisi; Andrea Matteucci; Claudio Frank; Marco Diociaiuti
Journal:  Int J Alzheimers Dis       Date:  2011-02-08

9.  Recombinant pro-CTSD (cathepsin D) enhances SNCA/α-Synuclein degradation in α-Synucleinopathy models.

Authors:  Susy Prieto Huarcaya; Alice Drobny; André R A Marques; Alessandro Di Spiezio; Jan Philipp Dobert; Denise Balta; Christian Werner; Tania Rizo; Lisa Gallwitz; Simon Bub; Iva Stojkovska; Nandkishore R Belur; Jens Fogh; Joseph R Mazzulli; Wei Xiang; Amitkumar Fulzele; Mario Dejung; Markus Sauer; Beate Winner; Stefan Rose-John; Philipp Arnold; Paul Saftig; Friederike Zunke
Journal:  Autophagy       Date:  2022-04-28       Impact factor: 13.391

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.